CRISPR-Cas

Een grote mammoet in de sneeuw.

Viewpoint: Return of the mammoth? ‘I fear backlash against CRISPR technology’

Science
American dream of mammoth calf sounds more like a nightmare to Wageningen biotechnologist.

Live&Learn: John van der Oost

Science
Failure is useful. Therefore, this feature is about what didn’t work out.
RNA

Altruism in bacteria

Science
Unlike most CRISPR-Cas systems, this one detects RNA rather than DNA.

‘Scientists are never objective’

In-depth
Young scientists discuss CRISPR-Cas after Zembla programme.

Sharpening the CRISPR-Cas scissors

Science
PhD candidate Thomas Swartjes is using bacterial sex to improve the snipper…

Should the EU allow CRISPR-Cas?

In-depth
Science
Four WUR scientists on the question: Should the EU allow CRISPR-Cas?

You win some, you lose some : Eveline Verhulst

Science
Failure is useful. Therefore, this feature is about what didn’t work out.

Four uncertainties on free CRISPR-Cas patents

In-depth
Organisation
Student Sophie van Wijk: how to end world hunger with free patents.

Wen Ying Wu wins Cover Prize

Science
Jury and public are in agreement on which is the best thesis…

What is the scope of the Wageningen CRISPR-Cas patents?

Science
The answer is complicated. See below.

Contact
Privacy statement

Follow us
This site uses cookies. Check our privacy statement for more information.